* Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a
fall
in quarterly revenue when it reports results on August 10.
* The New York City-based company is expected to report a
51.4% decrease in revenue to $14.14 million from $29.09 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc
is for
a loss of 14 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $16, above its last closing price of $7.14.
This summary was machine generated August 8 at 13:56 GMT. All
figures in US dollars unless otherwise stated